These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15792615)

  • 1. Antiviral activity of Cidofovir on a naturally human papillomavirus-16 infected squamous cell carcinoma of the head and neck (SCCHN) cell line improves radiation sensitivity.
    Sirianni N; Wang J; Ferris RL
    Oral Oncol; 2005 Apr; 41(4):423-8. PubMed ID: 15792615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers.
    Abdulkarim B; Sabri S; Deutsch E; Chagraoui H; Maggiorella L; Thierry J; Eschwege F; Vainchenker W; Chouaïb S; Bourhis J
    Oncogene; 2002 Apr; 21(15):2334-46. PubMed ID: 11948417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis.
    Ferris RL; Martinez I; Sirianni N; Wang J; López-Albaitero A; Gollin SM; Johnson JT; Khan S
    Eur J Cancer; 2005 Mar; 41(5):807-15. PubMed ID: 15763658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cidofovir is active against human papillomavirus positive and negative head and neck and cervical tumor cells by causing DNA damage as one of its working mechanisms.
    Mertens B; Nogueira T; Stranska R; Naesens L; Andrei G; Snoeck R
    Oncotarget; 2016 Jul; 7(30):47302-47318. PubMed ID: 27331622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N; Ha PK; Oelke M; Califano J; Gooding W; Westra W; Whiteside TL; Koch WM; Schneck JP; DeLeo A; Ferris RL
    Clin Cancer Res; 2004 Oct; 10(20):6929-37. PubMed ID: 15501971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects of acyclic nucleoside phosphonates on human papillomavirus (HPV)-harboring cell lines compared with HPV-negative cell lines.
    Andrei G; Snoeck R; Piette J; Delvenne P; De Clercq E
    Oncol Res; 1998; 10(10):523-31. PubMed ID: 10338155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2007 Aug; 29(8):741-50. PubMed ID: 17252592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cidofovir induces an increase in levels of low-risk and high-risk HPV E6.
    Donne AJ; Hampson L; He XT; Rothera MP; Homer JJ; Hampson IN
    Head Neck; 2009 Jul; 31(7):893-901. PubMed ID: 19283851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of the antiviral agent cidofovir and anti-EGFR antibody cetuximab exerts an antiproliferative effect on HPV-positive cervical cancer cell lines' in-vitro and in-vivo xenografts.
    Deberne M; Levy A; Mondini M; Dessen P; Vivet S; Supiramaniam A; Vozenin MC; Deutsch E
    Anticancer Drugs; 2013 Jul; 24(6):599-608. PubMed ID: 23698251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha interferon augments cidofovir's antiviral and antiproliferative activities.
    Johnson JA; Gangemi JD
    Antimicrob Agents Chemother; 2003 Jun; 47(6):2022-6. PubMed ID: 12760891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Abdulkarim B; Sabri S; Zelenika D; Deutsch E; Frascogna V; Klijanienko J; Vainchenker W; Joab I; Bourhis J
    Oncogene; 2003 Apr; 22(15):2260-71. PubMed ID: 12700662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p16, Rb, and p53 proteins in squamous cell carcinomas of the anorectal region harboring human papillomavirus DNA.
    Lu DW; El-Mofty SK; Wang HL
    Mod Pathol; 2003 Jul; 16(7):692-9. PubMed ID: 12861066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
    Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
    Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demographic and risk factors in patients with head and neck tumors.
    Tachezy R; Klozar J; Rubenstein L; Smith E; Saláková M; Smahelová J; Ludvíková V; Rotnáglová E; Kodet R; Hamsíková E
    J Med Virol; 2009 May; 81(5):878-87. PubMed ID: 19319944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.
    Rampias T; Sasaki C; Weinberger P; Psyrri A
    J Natl Cancer Inst; 2009 Mar; 101(6):412-23. PubMed ID: 19276448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.